Nuveen’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Nuveen’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-307,547	Closed	-$2.39M	–	3369
2020 Q2	$2.39M	Buy	307,547 +6,372	+2%	+$88.6K	﹤0.01%	2260
2020 Q1	$2.15M	Buy	301,175 +1,784	+0.6%	+$22.3K	﹤0.01%	2154
2019 Q4	$7.15M	Sell	299,391 -3,110	-1%	-$85.8K	﹤0.01%	1790
2019 Q3	$8.11M	Buy	302,501 +46,662	+18%	+$1.31M	﹤0.01%	1690
2019 Q2	$6.94M	Buy	+255,839	New	+$8.02M	﹤0.01%	1815
2018 Q1	–	Sell	-12,079	Closed	-$588K	–	1168
2017 Q4	$588K	Buy	+12,079	New	+$611K	﹤0.01%	872

Nuveen's PTLA Position: Q3 2020 in Review

Nuveen sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 307,547 shares — an estimated $2.39M sold.

Nuveen first reported a position in PTLA in Q4 2017 and held it in 6 quarters. The position peaked at $8.11M in Q3 2019. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Nuveen reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Nuveen sold 307,547 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $2.39M.
Nuveen first reported a position in Portola Pharmaceuticals, Inc. in Q4 2017 and held it in 6 quarters.
Nuveen's Portola Pharmaceuticals, Inc. position peaked at $8.11M in Q3 2019.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Nuveen's 13F filing for Q3 2020, filed 16 Nov 2020.